🔎 Trials Near Me

Akèy › Kansè kolon › Texas › Houston

Etid klinik pou Kansè kolon nan Houston, TX

20 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Ap rekriteFaz 1
  • ALX Center 5, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1
  • PHN-012-001 Site, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ap rekriteFaz 3
  • Oncology Consultants P.A., Houston
  • Oncology Consultants P.A., Houston
  • Texas Oncology - Gulf Coast, Houston
  • ak 7 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • MD Anderson, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Ap rekriteFaz 1/2
  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07705334

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Ap rekriteFaz 2/3
  • Lyndon Baines Johnson General Hospital, Houston
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • Ben Taub General Hospital, Houston
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05174169

Shield Post-Approval Study Protocol

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Integrity Advanced Therapeutics, PLLC, Houston
Laj 45 a 81 · Tout sèks · Mizajou Aug 7, 2026 · NCT06880055

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • The University of Texas - M.D. Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07318805

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Ap rekriteFaz 1
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Ap rekriteFaz 1
  • Research Site, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Ap rekriteFaz 1
  • University of Texas, MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Ap rekriteFaz 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Ap rekriteEtid obsèvasyon
  • M.D. Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT00843375

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06239194

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Houston
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Ap rekriteFaz 2
  • Baylor College of Medicine, Houston
Laj 18 a 80 · Tout sèks · Mizajou May 25, 2025 · NCT05870800

Etid Kansè kolon nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.